Physician profile
Samuel E Bledsoe
NPI 1033367446
$52,664.90
in general payments reported to CMS, 2019-2025
17 companies · $876 in 2025
The $876 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $66.66 · 2021: $14K · 2022: $12K · 2023: $9,488 · 2024: $16K · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Consulting Fee: $9,595 · Food and Beverage: $2,561 · Travel and Lodging: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,500.00 |
| Consulting Fee | $9,595.00 |
| Food and Beverage | $2,561.41 |
| Travel and Lodging | $1,287.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $33,450.62 | 2021-2023 | Echelon; Endopath, Echelon Flex, Harmonic |
| Intuitive Surgical, INC. | $14,572.40 | 2022-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $3,489.95 | 2019-2025 | Echelon Flex, Echelon; Endopath, Vistaseal |
| Medtronic, INC. | $392.45 | 2022-2023 | Interstim, Signia, Tourguide Steerable Sheath |
| Davol INC. | $344.02 | 2021-2024 | Phasix Mesh |
| Novo Nordisk INC | $139.11 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Reshape Lifesciences INC. | $49.35 | 2022 | |
| Abbott Laboratories | $49.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.27 | 2024 | Xarelto |
| Terumo Medical Corporation | $26.75 | 2023 | Azur Cx Detachable |
| Boston Scientific Corporation | $26.52 | 2021 | |
| Teleflex LLC | $23.17 | 2025 | Titan Sgs Bailout Chuck |
| Astrazeneca Pharmaceuticals LP | $19.32 | 2025 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $15.95 | 2025 | Eliquis |
| Solventum Corporation | $15.62 | 2024 | Ranger |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microline Surgical INC | $12.81 | 2024 | |
| Inari Medical, INC. | $9.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Bledsoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.